Vericept Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Vericept General Information

Description

Provider of enterprise risk management solutions. The company develops fraud and identity theft solution designed to help companies safeguard valued customer data, including social security numbers, credit card information and other personal information, from internal and external threats.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Security Services (B2B)
Other Industries
Application Software
Acquirer
Primary Office
  • 750 West Hamdpen Avenue
  • Suite 550
  • Englewood, CO 80110
  • United States
+1 (303) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vericept Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 10-Sep-2009 0000 Completed Generating Revenue
12. Convertible Debt 21-Jul-2008 00000 0000 Completed
11. Convertible Debt 14-Jul-2008 00.000 000.00 Completed
10. Convertible Debt 12-Jun-2008 00000 000.00 Completed
9. Convertible Debt 12-Jun-2008 00000 000.00 Completed
8. Later Stage VC (Series B1) 05-Nov-2007 00.000 000.00 Completed Generating Revenue
7. Bridge 02-Oct-2007 000 000.00 Completed Generating Revenue/Not Profitable
6. Bridge 24-Jul-2007 00.000 000.00 Completed Generating Revenue/Not Profitable
5. Bridge 09-Mar-2007 $5.01M $54.1M Completed Generating Revenue/Not Profitable
4. Later Stage VC (Series D) 30-May-2006 $21.6M $49.1M 000.00 Completed Generating Revenue
To view Vericept’s complete valuation and funding history, request access »

Vericept Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 8,797,323 $0.001000 8% $1.27 $1.27 1x $0.7 24.35%
Series A 158,500 $0.001000 8% $10
To view Vericept’s complete cap table history, request access »

Vericept Executive Team (6)

Name Title Board Seat Contact Info
Brett Schklar Senior Director, Marketing and Product
You’re viewing 1 of 6 executive team members. Get the full list »

Vericept Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Globespan Capital Partners Venture Capital Minority 000 0000 000000 0
Sequel Venture Partners Venture Capital Minority 000 0000 000000 0
Sigma Partners Venture Capital Minority 000 0000 000000 0
Western Technology Investment Venture Capital Minority 000 0000 000000 0
William Blair Capital Partners PE/Buyout Minority 000 0000 000000 0
To view Vericept’s complete investors history, request access »